BiomX (PHGE) Assets (2018 - 2026)
BiomX (PHGE) posted Assets of $3.3 million for Q1 2026, down 43.78% sequentially from $5.8 million in Q4 2025, and down 92.88% YoY from $45.7 million in Q1 2025.
BiomX (PHGE) Assets (2018 - 2026) Analysis & Trends
BiomX has reported Assets for 9 years, with the latest figure at $3.3 million in Q1 2026.
- Quarterly Assets fell 92.88% year-over-year to $3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.3 million (down 92.88% YoY) and the FY2025 annual result came in at $5.8 million, down 86.62% from the prior year.
- Assets slipped to $3.3 million in Q1 2026 per PHGE's latest filing, from $5.8 million in the prior quarter.
- Over five years, Assets peaked at $68.7 million in Q1 2022 and troughed at $3.3 million in Q1 2026.
- A 5-year average of $40.4 million and a median of $41.4 million in 2023 frame the typical range for Assets.
- The sharpest annual moves came in 2024 and 2026: Assets surged 81.45% in 2024, then sank 92.88% in 2026.
- Over 5 years, Assets stood at $45.5 million in 2022, then sank by 45.03% to $25.0 million in 2023, then jumped by 72.73% to $43.2 million in 2024, then slumped by 86.62% to $5.8 million in 2025, then slumped by 43.78% to $3.3 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $3.3 million, $5.8 million, and $26.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | BiomX | 361,408.40 | -806,591.60 | - | 3.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.25 Mn |
| Dec 31, 2025 | 5.78 Mn |
| Sep 30, 2025 | 26.17 Mn |
| Jun 30, 2025 | 38.05 Mn |
| Mar 31, 2025 | 45.65 Mn |
| Dec 31, 2024 | 43.23 Mn |
| Sep 30, 2024 | 59.98 Mn |
| Jun 30, 2024 | 68.62 Mn |
| Mar 15, 2024 | 29.93 Mn |
| Dec 31, 2023 | 25.03 Mn |
| Sep 30, 2023 | 33.06 Mn |
| Jun 30, 2023 | 41.25 Mn |
| Mar 31, 2023 | 41.41 Mn |
| Dec 31, 2022 | 45.53 Mn |
| Sep 30, 2022 | 51.90 Mn |
| Jun 30, 2022 | 58.38 Mn |
| Mar 31, 2022 | 68.74 Mn |
| Dec 31, 2021 | 77.99 Mn |
| Sep 30, 2021 | 81.80 Mn |
| Jun 30, 2021 | 61.65 Mn |